Cyclacel announces amendment to exchange agreement with Fitters
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 07 2025
0mins
Transaction Details: Cyclacel Pharmaceuticals has amended its Exchange Agreement with FITTERS Diversified Berhad, allowing for the exchange of shares from FITTERS' subsidiary for common stock in Cyclacel, along with a cash payment of $1,000,000 at closing.
Approval and Timeline: The agreement has been unanimously approved by the Boards of Directors of both companies and is subject to approval from stockholders, with the final date for the transaction extended to September 30, 2025.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





